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Reactive oxygen species (ROS) are independently recognized to play a significant role in radiation-induced damage on healthy
tissue and in aging process. However, an age-related alteration of antioxidant (AO) system in radiation response in humans is
poorly investigated. The aim of this paper was to evaluate the irradiation eﬀects on the activities and expression of AO system in
the blood of healthy women during aging. Blood samples were irradiated with curative and palliative doses of 2Gy or 9Gy γ-rays.
AO capacity for detoxification of O2•− and H2O2 in response to 2Gy γ-irradiation decreases in women above 58 years, while in
response to 9Gy shows signs of weakening after 45 years of age. Due to reduction of AO capacity during aging, cytotoxic eﬀects of
curative and palliative doses of irradiation, mediated by ROS, may significantly increase in older subjects, while removal of H2O2
excess could reduce them.
1. Introduction
Radiotherapy of cancer tumors is based on the possibility of
tumor cell death induction mediated by the direct damages
of DNA molecules, as well as by the high local production
of reactive oxygen species (ROS) [1]. Radiochemical changes
occurs within 10–13 seconds, including the generation of
O2•−, •OH, and H2O2, and other free radicals attributable
to chemical interactions between high-energy electrons,
photons, and the molecular targets of oxygen and water
within cells. The secondary radicals are formed by the
interaction of •OH with organic molecules [2]. Oxidative
damage of biomolecules formed by the action of ROS, which
exceeds the antioxidant (AO) and DNA repair capacity and
leads to a cell death, is a favorable outcome for the tumor
cells, but is a highly undesired event for the healthy tissues
[3]. Severe side eﬀects commonly arising from radiotherapy
often prevent patients from completing the treatment course.
Thus, scavenging ROS and inhibiting lipid peroxidation
are among possible key target activities for developing
successful radioprotection strategies. Since the degree of
radiation-induced damage on healthy tissue determines the
quality of life after radiotherapy, AO enzymes involved in
radioprotective mechanisms [4, 5], as well as in mechanisms
of radiosensitivity and radioresistance [6–10] are the subject
of intensive researches.
Our previous research showed that the activity of
manganese superoxide dismutase (MnSOD) is inversely
correlated with the yield of γ-radiation-induced micronuclei
in vitro in healthy human blood lymphocytes, suggesting
a base for a rapid predictive assay of radiosensitivity in a
clinical setting [7]. Our results also showed that activity of
SOD, particularly MnSOD, significantly contributes to the
relative biological eﬀectiveness and radiosensitivity to proton
irradiation in vitro as measured by the dose-dependent
production of dicentrics and micronuclei in healthy human
lymphocytes [11].
ROS (oxidative stress) is independently recognized to
play a significant role in radiation-induced damage on
healthy tissue [12, 13] and in aging process [14, 15]. How-
ever, an age-related modulation of AO system and AO en-
zyme expression in radiation response in humans is poorly
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investigated. The only obtainable report was given by
Lenton and Greenstock [16], who showed inverse rela-
tionship between human plasma radioprotective ability to
26Gy γ-irradiation and donor age, based on total plasma
AO capacity. Thus, in this work we investigated the AO
enzyme activities of copper, zink superoxide dismutase
(CuZnSOD), catalase (CAT), glutathione peroxidase (GPx),
and glutathione reductase (GR), as well as concentration of
glutathione (GSH) in blood cells of healthy women after
in vitro γ-irradiation of blood. Women were divided into
three age groups, younger then 45 years, aged 45–58 years,
and older then 58 years. The level of CuZnSOD protein was
measured to estimate whether the changes in activities were
related to the protein level of this enzyme, since in our pre-
vious work we found that radiotherapy reduces CuZnSOD
activity through the mechanism of reduced synthesis of this
enzyme [17]. Doses of 2Gy and 9Gy γ-rays were chosen as a
representative for daily clinical doses of 1.8–2Gy in curative
radiotherapy and 8–10Gy in palliative radiotherapy. They
correspond to cumulative concentrations of 2 × 106 M and
9 × 106 M of diﬀerent ROS [18]. This study is of significant
importance to cancer patients since rapidly dividing cells of
the blood system are highly prone to irradiation-induced
damage [19].
2. Materials andMethods
2.1. Reagents. All reagents were purchased from Sigma (St.
Louis, MO, USA), and Merck (Darmstadt, Germany). Assays
for CuZnSOD, GPx, GR, and GSH were purchased from
BioxytechR Assays (OXIS International Inc., Portland, OR,
USA). Rabbit anti-CuZnSOD polyclonal antibody (SOD-
100) and alkaline phosphatase-conjugated goat anti-rabbit
IgG (SAB-301) were purchased from Stressgen Biotechnolo-
gies (Victoria, Canada).
2.2. Subjects. The study included fifty-four healthy women,
selected from the routine control examinations of employees
and retirees, in the Department of Radiological Health
Protection of Vincˇa Institute of Nuclear Sciences, University
of Belgrade, Belgrade, Serbia. They were divided according
to their age into the age groups of younger than 45 years
(number of subjects, n = 13, median age in years: 33, range
in years: 24–42), 45–58 years (n = 23, median age: 53,
range: 45–58) and above 58 years (n = 18, median age: 71,
range: 63–80). The subjects in the youngest age group had
regular menstrual cycles, those in the middle-aged group
were menopausal, while those in the oldest age group were
postmenopausal. Participants were nonsmokers, and they
used no alcohol consumption, hormones, oral contracep-
tives, or dietary supplements with antioxidants. None of the
subjects had diseases such as diabetes mellitus, rheumatoid
arthritis, liver disorders, or any malignancies. According to
the ethical guidelines of the Helsinki Declaration, informed
consent was obtained from all participants and the protocol
used in this study was approved by the Ethics Committee of
Vincˇa Institute of Nuclear Sciences, University of Belgrade,
Belgrade, Serbia.
2.3. Irradiation. Blood samples were obtained after an
overnight fast by venous arm puncture in lithium-
heparinized tubes. Each blood sample was divided into the
triplicate aliquots and placed into plastic syringes under the
sterile conditions (Holten Laminar Air, Heto-Holten A/S,
Allerod, Denmark). They were positioned in a plexiglas
container 15 × 15 cm2, and irradiated with 2Gy or 9Gy
dose using 60Co as a source of γ-radiation (Cobaltron-
Therapeutic gamma source, Electronic Industry Nisˇ, Serbia).
Dose-rate was 0.333Gy/min and the dimension of radiation
field was 15 × 15 cm2. Samples were irradiated at room
temperature. Nonirradiated samples served as controls.
2.4. Blood Samples. After irradiation blood sample triplicates
were prepared for the in vitro culturing under sterile
conditions (Holten Laminar Air). Blood cultures containing
0.5mL of blood, 5mL of RPMI-1640 medium with gluta-
max, and 10% fetal bovine serum, were kept for 48 h, at 37◦C,
and 5% CO2 concentration (Sanyo CO2 incubator, Sanyo
Electric Co., Ltd., Gunma, Japan). Cells were spun down by
the centrifugation at 230 g, for 5min, at 4◦C (Beckman JA20
centrifuge, Beckman Instruments Inc., Palo Alto, CA, USA),
and medium and serum were removed. Cells were washed
three times in cold 0.9% NaCl and centrifuged at 230 g, for
5min, at 4◦C.
Blood cells from the pellet were lysed in 2 volumes
of ice-cold demineralized ultrapure water (MilliQ reagent
grade water system, Millipore Corp., Bedford, MA, USA)
and crude lysate were kept frozen at −70◦C, before being
used for clarified lysate preparations. The crude lysates
were used for CAT and GPx assays and protein con-
centration measurements. Hemoglobin was removed from
crude lysate by adding chloroform and ethanol (propor-
tions of lysate : chloroform : ethanol was 1 : 1 : 0.6) and after
centrifugation at 3000 g, for 10min, at 4◦C (Eppendorf
centrifuge 5417, Eppendorf AG, Hamburg, Germany), the
upper aqueous layer was collected and used for CuZnSOD
activity assay, SDS-PAGE electrophoresis, and western blot
analyses. After removing blood cell stroma from crude lysate
by centrifugation at 8600 g, for 10min, at 4◦C (Eppendorf
centrifuge 5417), clarified lysate was used for GR assay. After
protein precipitation from crude lysate, with trichloroacetic
acid contained in precipitation reagent (Oxis Bioxytech
GSH-420 Assay; Oxis International, Inc., Portland, OR, USA;
proportions for lysate : precipitation reagent was 1 : 3) and
centrifugation at 10000 g, for 5min, at room temperature
(Eppendorf centrifuge 5417), supernatant was used for GSH
assay.
2.5. Enzyme Assays
2.5.1. Assay of SOD Activity. Determination of SOD activity
was performed using Oxis Bioxytech SOD-525 Assay (Oxis
International, Inc., Portland, OR, USA). Themethod is based
on SOD-mediated increase of autoxidation of 5,6,6a,llb-
tetrahydro-3,9,10-tryhydroxybenzo[c]fluorene in aqueous
alkaline solution to yield a chromophore with maximum
absorbance at 525 nm. The SOD activity is determined from
the ratio of the autoxidation rates in the presence (Vs) and
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in the absence (Vc) of SOD. One SOD-525 activity unit is
defined as the activity that doubles the autoxidation rate of
the control blank (Vs/Vc = 2).
2.5.2. Assay of CAT Activity. CAT activity was determined by
the method of Beutler [20]. The reaction is based on the rate
of H2O2 degradation by catalase contained in the examined
samples. The reaction was performed in an incubation
mixture containing 1M Tris-HCl, 5mM EDTA, pH 8.0, and
monitored spectrophotometrically at 230 nm. One unit of
CAT activity is defined as 1 μmol of H2O2 decomposed per
minute under the assay conditions.
2.5.3. Assay of GPX Activity. GPx activity was assessed using
the Oxis Bioxytech GPx-340 Assay (Oxis International, Inc.,
Portland, OR, USA), based on the principle that oxidized
glutathione (GSSG) produced upon reduction of an organic
peroxide by GPx is immediately recycled to its reduced form
(GSH) with concomitant oxidation of NADPH to NADP+.
The oxidation of NADPH was monitored spectrophotomet-
rically as a decrease in absorbance at 340 nm. One GPx-
340 unit is defined as 1 μmol of NADH oxidized per minute
under the assay conditions.
2.5.4. Assay of GR Activity. Activity of GR was measured
using the Oxis Bioxytech GR-340 Assay (Oxis International,
Inc., Portland, OR, USA). The assay is based on the oxidation
of NADPH to NADP+ during the reduction of oxidized
glutathione (GSSG), catalyzed by a limiting concentration of
glutathione reductase. The oxidation of NADPH was moni-
tored spectrophotometrically as a decrease in absorbance at
340 nm. One GR-340 unit is defined as 1 μmol of NADH
oxidized per minute under the assay conditions.
2.5.5. GSH Concentration. The concentration of GSH was
measured by Oxis Bioxytech GSH-420 Assay (Oxis Inter-
national, Inc., Portland, OR, USA), which is based on the
reaction of 4-chloro-1-methyl-7-trifluoromethylquinolini-
um and all thiols to form thioethers. Upon addition of base
to raise the pH above 13, a β-elimination specific to the GSH-
thioether results in production of the chromophoric thione,
which is measured at 420 nm.
The enzyme assays and concentration measurements
were monitored spectrophotometrically (Perkin Elmer spec-
trophotometer, λ25, Perkin Elmer Instruments, Norwalk,
CT, USA). The enzyme activities were expressed in U
or mU per milligram of total cell protein. GSH and LP
concentration was expressed in nmol/mg protein and pmol/
mg protein, respectively. Determination of protein concen-
tration was performed by the method of Lowry et al. [21]
and expressed in mg/mL.
2.6. Electrophoresis and Western Blot. For the SDS-PAGE
electrophoresis equal amounts of protein were dissolved
in SDS-PAGE sample loading buﬀer and electrophoresed
in 10% polyacrylamide gel (Mini-Protean 3 Cell, Bio-
Rad Laboratories, Inc., Hercules, CA, USA), according to
Laemmli [22]. For Western blot analysis, the proteins were
transferred to nitrocellulose membranes (Trans- Blot SD
Semi- Dry Electrophoretic Transfer Cell, Bio-Rad, Hercules,
CA, USA). Non-specific binding sites on membranes were
blotted with TBST (10mM Tris, 150mM NaCl, 0.1% Tween
20) containing 1% BSA and then probed with rabbit
anti-CuZnSOD polyclonal antibody (SOD-100, Stressgen
Biotechnologies, Victoria, Canada) and rabbit anti-actin
antibody (C-11: 1615, Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Alkaline phosphatase-conjugated goat anti-rabbit
IgG (SAB-301, Stressgen Biotechnologies, Victoria, Canada)
was used for detection purposes. Each blot was ran in
triplicate and scanned. The density of bands was determined
by ImageJ processing program, normalized to the level of
actin and expressed as percent of value found in the control
samples, which were consider as 100%.
2.7. Statistical Analyses. Statistical analyses were performed
by using the statistical software package OriginPro 8.0.
Variations of AO parameters were tested with Student’s
paired t-test. Data were tested at a statistical significance level
of P < 0.05 and expressed as mean ± SEM.
3. Results
3.1. Eﬀects of In Vitro γ-Irradiation on AO Status in the Blood
Cells of Healthy Women. The dose of 2Gy γ-irradiation, in
the age group under 45 years, increased the activities of
SOD (5.00 ± 0.22 versus 5.81 ± 0.38U/mg prot., Student’s
paired t-test: P < 0.05), CAT (102.17 ± 7.99 versus 117.37 ±
9.11U/mg prot., P < 0.05), GPx (19.82 ± 1.19 versus
21.02 ± 1.10mU/mg prot., P < 0.05), and GR (4.22 ± 0.41
versus 4.71 ± 0.48 mU/mg prot., P < 0.05), and lowered the
level of GSH (5.31 ± 0.54 versus 4.88 ± 0.47 nmol/mg prot.,
P < 0.01), when compared to nonirradiated control values
(Figure 1).
In the group aged 45–58 years, the dose of 2Gy increased
the activities of SOD (4.82 ± 0.24 versus 5.41 ± 0.28 U/mg
prot., P < 0.01), GPx (17.60 ± 0.93 versus 19.21 ±
0.93mU/mg prot., P < 0.01), and GR (4.56 ± 0.35 versus
5.14 ± 0.37 mU/mg prot., P < 0.05), had no eﬀect on the
activity of CAT (103.99 ± 6.29 versus 110.60 ± 6.66 U/mg
prot., P > 0.05), and decreased the level of GSH (4.72± 0.42
versus 3.82 ± 0.33 nmol/mg prot., P < 0.01) in comparison
to control values (Figure 2).
In the age group above 58 years, the equal dose of γ-rays
decreased the activities of SOD (6.15±0.26 versus 4.89±0.34
U/mg prot., P < 0.01), CAT (122.66 ± 7.51 versus 113.51 ±
6.70 U/mg prot., P < 0.05), GPx (18.60 ± 0.88 versus 17.84±
0.84 mU/mg prot., P < 0.05), and GR (4.64 ± 0.40 versus
4.41 ± 0.41 mU/mg prot., P < 0.05) and lowered the level of
GSH (5.04±0.37 versus 4.19±0.30 nmol/mg prot., P < 0.01)
(Figure 3).
The dose of 9Gy γ-irradiation uniformly decreased the
activities of AO enzymes and the level of GSH in all examined
age groups of subjects, when compared to nonirradiated
control values. The values of AO parameters for the control
samples versus irradiated samples were as follows:
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Figure 1: AO enzyme activities and concentration of GSH in blood cells nonirradiated (C) and irradiated with 2Gy and 9Gy of γ-radiation,


































































































Figure 2: AO enzyme activities and concentration of GSH in blood cells nonirradiated (C) and irradiated with 2Gy and 9Gy of γ-radiation,
in healthy women aged 45–58 years. The data are given in mean values± SEM; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 in comparison to C
(student’s paired t-test).
(a) in the group under 45 years: SOD (5.00 ± 0.22
versus 4.15 ± 0.24U/mg prot., Student’s paired t-
test: P < 0.01), CAT (102.17 ± 7.99 versus 89.41 ±
7.66U/mg prot., P < 0.05), GPx (19.82± 1.19 versus
18.16±0.79 mU/mg prot., P < 0.05), GR (4.22±0.41
versus 3.78± 0.37 mU/mg prot., P < 0.01), and GSH
(5.31 ± 0.54 versus 4.59 ± 0.47 nmol/mg prot., P <
0.01) (Figure 1);
(b) in the group aged 45–58 years: SOD (4.82 ± 0.24
versus 3.47 ± 0.16U/mg prot., P < 0.001), CAT
(103.99 ± 6.29 versus 89.95 ± 4.70 U/mg prot., P <
0.01), GPx (17.60± 0.93 versus 16.53± 0.73 mU/mg
prot., P < 0.01), GR (4.56 ± 0.35 versus 4.10 ± 0.30
mU/mg prot., P = 0.05), and GSH (4.72±0.42 versus
3.96± 0.35 nmol/mg prot., P < 0.01) (Figure 2);
(c) in the group above 58 years: SOD (6.15± 0.26 versus
4.64 ± 0.27 U/mg prot., P < 0.001), CAT (122.66 ±
7.51 versus 96.71 ± 6.76 U/mg prot., P < 0.01), GPx
(18.60 ± 0.88 versus 17.41 ± 0.81 mU/mg prot., P <
0.01), GR (4.64 ± 0.40 versus 4.06 ± 0.46mU/mg
prot., P < 0.01), and GSH (5.04± 0.37 versus 4.10±
0.30 nmol/mg prot., P = 0.01) (Figure 3).



































































































Figure 3: AO enzyme activities and concentration of GSH in blood cells nonirradiated (C) and irradiated with 2Gy and 9Gy of γ-radiation,
in healthy women above 58 years. The data are given in mean values± SEM; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 in comparison to C
(student’s paired t-test).
3.2. Eﬀects of In Vitro γ-Irradiation on SOD Protein Level
in the Blood Cells of Healthy Women. A dose of 2Gy, 48
hours after γ-irradiation, did not significantly change the
level of blood cells SOD protein, in the group of subjects
younger than 45 years (101.83 ± 6.32%, Student’s paired t-
test: P > 0.05; Figure 4), neither in the group aged 45 to
58 years (100.22 ± 7.57%, P > 0.05; Figure 5), nor in the
group older than 58 years (90.90±3.76%, P > 0.05; Figure 6),
when compared to the age-matched nonirradiated controls
(100%).
Dose of 9Gy, 48 hours after γ-irradiation, also, did not
significantly aﬀect protein levels of this enzyme in the blood
cells of the youngest (90.43 ± 6.79%, P > 0.05; Figure 4),
middle-aged (89.12 ± 6.41%, P > 0.05; Figure 5), or elderly
subjects (89.63 ± 5.61%, P > 0.05; Figure 6) in comparison
with the age-matched nonirradiated controls (100%).
4. Discussion
Results of this work showed that AO response to 2Gy of
γ-radiation in blood cells of healthy women was similar in
age groups younger than 45 years and aged 45–58 years. It
involved increased activities of CuZnSOD, CAT, GPx, andGR
and lowered level of GSH (Figures 1 and 2). Contrary, in the
age group above 58 years the same dose of γ-rays lowered
the activities of SOD, CAT, GPx, and GR, as well as the level
of GSH (Figure 3). A dose of 9Gy uniformly suppressed the
activities of AO enzymes and lowered the level of GSH in
healthy women independently of age. Suppressive eﬀects of
this dose on CuZnSOD, CAT, and GPx activity were more
pronounced in groups aged 45–58 years and above 58 years
(Figures 2 and 3), when compared to age group younger then
45 years (Figure 1). This shows that AO protective capacity
in response to acute γ-radiation depends on age in women,






























Figure 4: Relative level of CuZnSOD protein in blood cells nonir-
radiated (C) and irradiated with 2Gy and 9Gy of γ-radiation, in
healthy women younger than 45 years. Relative values are expressed
as percent of value found in the nonirradiated control group, which
is considered as 100% (student’s paired t-test).
of age, while in a case of 9Gy dose shows signs of slight
weakening already after 45 years of age.
Under oxidative stress conditions, increased level of
ROS can damage the variety of biomolecules, including
AO enzymes. Increased rate of ROS production commonly
elicits, as a response, an increase in activities of AO enzymes.
Still, under high rate of ROS input, the enzyme inactivation
prevails, leading to reduced AO enzyme activities [23, 24]
and to autocatalysis of oxidative damage process. Thus,
cumulative increase of ROS induced by aging process and
acute γ-irradiation may be the cause for observed decrease
of AO protective capacity in response to both doses of γ-
irradiation.






























Figure 5: Relative level of CuZnSOD protein in blood cells nonir-
radiated (C) and irradiated with 2Gy and 9Gy of γ-radiation, in
healthy women aged 45–58 years. Relative values are expressed as
percent of value found in the nonirradiated control group, which is





























Figure 6: Relative level of CuZnSOD protein in blood cells non-
irradiated (C) and irradiated with 2Gy and 9Gy of γ-radiation,
in healthy women above 58 years. Relative values are expressed as
percent of value found in the nonirradiated control group, which is
considered as 100% (student’s paired t-test).
Free radicals and peroxides can be directly removed by
the action of reduced GSH, which is the main endogenous
soluble antioxidant and the key regulator of intracellular
redox status in mammalian cells [25]. GSH can act through
formation of a disulfide mixture or by oxidation to GSSG,
thus preventing damaging eﬀects on tissues caused by
hydrogen and organic peroxides [26]. A decreased level of
GSH may cause increased oxidative damage, both through
impairment of its direct antioxidant actions and through
indirect action, via decreasing GPx activity, where it is
necessary as a cosubstrate [27]. Protective role of GPx against
radiation stems from observation that GPx activity correlates
with radioresistence in several human cell lines [9]. It appears
that the reduction of GSH level in response to a dose of
2Gy in the youngest and middle-age group of women is
the consequence of its increased consumption, judged by
increased activity of GPx (Figures 1 and 2). Reduction of
GSH level in response to a dose of 2Gy in the oldest group
(Figure 3), as well as in response to a dose of 9Gy in
all age groups of women is probably due to its decreased
regeneration by GR (Figures 1, 2, and 3). This confirms
our previous results [28, 29], showing important role of the
glutathione redox cycle in AO protection against oxidative
stress in ionizing-radiation exposure and aging process.
ROS (oxidative stress) are recognized to play a significant
role in functional degeneration of somatic cells during aging
process [15]. Concerning the alteration of AO enzymes
during aging process, our previous work showed age-related
decrease of CuZnSOD and CAT activities in blood cells of
healthy women aged 45–58 years and above 58 years when
compared to women younger then 45 years [28]. Other
reports also showed age-related decrease of SOD activity in
erythrocytes [30–32] and whole blood [33] and decrease
of CAT activity in blood [34] in healthy humans. Age-
dependent diminishment in AO enzyme activity may be due
to a progressive enzyme inactivation by its product [23]; for
example, the production of mitochondrial H2O2 increases
with aging [35]. Also, it may be due to an increase in the
glycation of enzyme [36], deficiency of ions important for
maintaining the enzyme structure and catalytic function
[37], and disturbance of glutathione redox system [38].
These data support our present results, indicating that age-
related decrease in AO capacity may aﬀect AO response to
acute γ-irradiation.
Although ROS (oxidative stress) are independently rec-
ognized to play a significant role in radiation-induced
damage of healthy tissue [39] and in aging process [14], age-
related modulation of AO system in radiation response in
humans was poorly investigated. Investigation on humans
aged 30–80 years reported inverse relationship between
plasma radioprotective ability to in vitro 26Gy γ-irradiation
and donor age, based on total plasma AO capacity [16]. Study
on gerbils observed that AO potential of tissue homogenates
from older animals had a reduced ability to protect against
radiation-induced oxidative damage provoked by 60Gy X-
irradiation, measured by protein oxidation susceptibility.
The same study showed that activities of SOD, CAT, GPx,
and concentration of GSH did not exhibit a uniform pattern
of age-related changes [40]. Our previous report indicated
that radiotherapy with a fraction size of 2Gy X-radiation
for breast tumors and regional lymph nodes, includes age-
related decrease in AO capacity for elimination of H2O2
(decrease of GPx, GR activities, and GSH level). This caused
the occurrence of oxidative damages in blood cells of patient
above 58 years, when compared to patients aged 45–58
years [29]. Our previous and present results indicate that
age-related decrease in AO capacity aﬀects not only the
AO response to acute γ-irradiation with 2Gy, but also
to repeatedly delivered dozes of 2Gy X-irradiation during
radiotherapy. This is of particular interest for ionizing
radiotherapy, because about two-thirds of X-ray and γ-ray
damage is caused by their indirect action, via ROS, that
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kill tumor cells but threaten the integrity and survival of
surrounding normal cells [39, 41].
The alteration of AO enzyme expression in aging process
and radiation response in humans is also poorly docu-
mented. In vitro γ-irradiation of blood of breast cancer
patients with doses of 2Gy and 9Gy showed increased
expression of MnSOD and CAT, and unchanged expression
of CuZnSOD in leukocytes [42]. Higher activities and
expression of glutathione-S-transferase (GST) and CAT were
recorded in radioresistant variant of human glioblastoma cell
line after in vitro fractionated γ-irradiation with 3Gy [10]. In
our previous work we observed that the age-related decrease
in CuZnSOD activity in blood cells of healthy humans
is most likely caused by the posttranslational chemical
modification, without changes in protein synthesis of this
enzyme [28]. We also found that breast cancer radiotherapy
with a fraction size of 2Gy X-radiation provoked elevation
of blood cells CuZnSOD activity in patients aged 45–58
years and above 58 years, caused by the increase in protein
synthesis of this enzyme [17]. Results in this work show that
modulation of CuZnSOD activity in response to 2Gy and
9Gy doses of acute γ-irradiation were not caused by protein
level of this enzyme, which was found to be similar in aging
groups (Figures 4, 5, 6). Most probably it is due to post-
translational chemical modification of this enzyme under the
changed redox environment provoked by ionizing radiation.
Although statistically insignificant, the increase in CuZnSOD
activity coincided with its unchanged protein levels, while
decrease in activity coincided with its decreased protein levels
for about 10%. It may be noted that, while an acute 2Gy ion-
izing irradiation modifies CuZnSOD activity in blood cells
through faster mechanism of post-translational chemical
modification of enzyme, repetitively delivered 2Gy ionizing
irradiation during radiotherapy [17] modifies CuZnSOD
activity through slower, but more eﬃcient mechanism of
synthesis of this enzyme.
In conclusion, our results seem to be the first report
of deleterious contribution of aging process to decrease of
blood cell AO enzyme activities and GSH concentration in
ionizing-radiation response in humans. The protective AO
capacity for detoxification of O2•− and H2O2 in response
to 2Gy of in vitro γ-irradiation decreases in women above
58 years, due to decrease in CuZnSOD, CAT, GPx, and GR
activities. Also, AO capacity for detoxification of O2•− and
H2O2 in response to 9Gy dose shows signs of weakening
after 45 years of age, due to more pronounced decrease in
CuZnSOD, CAT, and GPx activities. Thus, AO response to
both doses seems to be age dependent. Modulation of CuZn-
SOD activity in response to both doses of acute γ-irradiation
was not caused by protein level of this enzyme and most
probably is due to post-translational chemical modification
of this enzyme. This suggests that, as a result of aging process,
decreased AO protection whichmaintains redox homeostasis
[43, 44], may significantly aﬀect the healthy cell response
to curative and palliative doses of therapeutic irradiation,
through toxic and/or redox regulative eﬀects of ROS. Also,
application of antioxidants that remove the excess of H2O2
possibly could reduce these side eﬀects.
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